BioCentury | Mar 11, 2019
Clinical News
Axovant reports first clinical gene therapy data
...AXO-Lenti-PD and ProSavin are each lentiviral gene therapies designed to deliver three genes -- TYH, GCH1...
...was up 3.40p to 713.30p on Monday. Targets: DDC (AADC) - Dopa decarboxylase; GCH1 - GTP cyclohydrolase 1...
...B; TYH - Tyrosine hydroxylase Sandi Wong, Staff Writer AXO-AAV-GM2 AXO-Lenti-PD, OXB-102 Sio Gene Therapies Inc. Dopa decarboxylase (DDC) (AADC) GTP cyclohydrolase 1 (GCH1) Hexosaminidase...
...was up 3.40p to 713.30p on Monday. Targets: DDC (AADC) - Dopa decarboxylase; GCH1 - GTP cyclohydrolase 1...
...B; TYH - Tyrosine hydroxylase Sandi Wong, Staff Writer AXO-AAV-GM2 AXO-Lenti-PD, OXB-102 Sio Gene Therapies Inc. Dopa decarboxylase (DDC) (AADC) GTP cyclohydrolase 1 (GCH1) Hexosaminidase...